L-Tyrosine-loaded nanoparticles increase the antitumoral activity of direct electric current in a metastatic melanoma cell model

International Journal of Nanomedicine

Volumn 5, Issue 1, 2010, Pages 961-971

  de Campos, Vânia Emerich Bucco ^a   Teixeira, Cesar Augusto Antunes ^a   da Veiga, Venicio Feo ^a   Ricci Jr , Eduardo ^a   Holandino, Carla ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

B16F10 cells; Cancer therapy; Direct electric current; L tyrosine; Nanotechnology

Indexed keywords

NANOPARTICLE; POLYCAPROLACTONE; TYROSINE; ANTINEOPLASTIC AGENT; POLYESTER; TRYPAN BLUE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; ELECTRIC CURRENT; ELECTRIC POTENTIAL; ELECTROSTIMULATION THERAPY; IN VITRO STUDY; MELANOMA; MELANOMA CELL; METASTASIS; NANOENCAPSULATION; NANOMEDICINE; NONHUMAN; PARTICLE SIZE; REACTION OPTIMIZATION; ANIMAL; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY; DRUG EFFECT; ELECTROCHEMICAL ANALYSIS; EXPERIMENTAL MELANOMA; METHODOLOGY; MOUSE; MULTIMODALITY CANCER THERAPY; PATHOLOGY; TRANSMISSION ELECTRON MICROSCOPY; TUMOR CELL LINE; ULTRASTRUCTURE;

MURINAE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; COMBINED MODALITY THERAPY; ELECTRIC STIMULATION THERAPY; ELECTROCHEMICAL TECHNIQUES; MELANOMA, EXPERIMENTAL; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; PARTICLE SIZE; POLYESTERS; TRYPAN BLUE; TYROSINE;

EID: 79954554256     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S13634     Document Type: Article

References (54)

1. Mora-Huertas CE, Fessi H, Elaissari A. Polymer-based nanocapsules for drug delivery. Int J Pharm. 2010;385(1-2):113-142.
2. Singh R, Lillard JW Jr. Nanoparticle-based targeted drug delivery. Exp Mol Pathol. 2009;86(3):215-223.
3. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release. 2001;70(1-2):1-20.
4. Hans ML, Lowman AM. Biodegradable nanoparticles for drug delivery and targeting. Curr Opin Solid State Mater Sci. 2002;6(4): 319-327.
5. Feng S, Huang G. Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers. J Control Release. 2001;71(1):53-69.
6. Farokhzad OC, Cheng J, Teply BA, et al. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc Natl Acad Sci U S A. 2006;103(16):6315-6320.
7. Alexis F, Rhee JW, Richie JP, Radovic-Moreno AF, Langer R, Farokhzad OC. New frontiers in nanotechnology for cancer treatment. Urol Oncol. 2008;26(1):74-85.
8. Chawla JS, Amiji MM. Biodegradable poly(epsilon-caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen. Int J Pharm. 2002;249(1-2):127-138.
9. Espuelas M, Legrand P, Campanero M, et al. Polymeric carriers for amphotericin B: in vitro activity, toxicity and therapeutic efficacy against systemic candidiasis in neutropenic mice. J Antimicrob Chemother. 2003;52(3):419-427.
10. Sinha VR, Bansal K, Kaushik R, Kumria R, Trehan A. Poly-epsiloncaprolactone microspheres and nanospheres: an overview. Int J Pharm. 2004;278(1):1-23.
11. Park SJ, Lee YM, Hong SK. Release behaviors of porous poly(butylene succinate)/poly(epsilon-caprolactone) microcapsules containing indomethacin. Colloids Surf B Biointerfaces. 2006;47(2):211-215.
12. Zili Z, Sfar S, Fessi H. Preparation and characterization of poly-epsiloncaprolactone nanoparticles containing griseofulvin. Int J Pharm. 2005; 294(1-2):261-267.
13. Shenoy DB, Amiji MM. Poly(ethylene oxide)-modified poly(epsiloncaprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer. Int J Pharm. 2005;293(1-2):261-270.
14. Singh J, Pandit S, Bramwell VW, Alpar HO. Diphtheria toxoid loaded poly-(epsilon-caprolactone) nanoparticles as mucosal vaccine delivery systems. Methods. 2006;38(2):96-105.
15. Yang J, Park SB, Yoon HG, Huh YM, Haam S. Preparation of poly epsilon-caprolactone nanoparticles containing magnetite for magnetic drug carrier. Int J Pharm. 2006;324(2):185-190.
16. Yenice I, Mocan M, Palaska E, et al. Hyaluronic acid coated polyepsilon- caprolactone nanospheres deliver high concentrations of cyclosporine A into the cornea. Exp Eye Res. 2008;87(3):162-167.
17. Benoit MA, Baras B, Gillard J. Preparation and characterization of protein-loaded poly(epsilon-caprolactone) microparticles for oral vaccine delivery. Int J Pharm. 1999;184(1):73-84.
18. Berman B, Perez O, Zell D. Immunological strategies to fight skin cancer. Skin Therapy Lett. 2006;11(5):1-7.
19. Tewes F, Munnier E, Antoon B, et al. Comparative study of doxorubicinloaded poly(lactide-co-glycolide) nanoparticles prepared by single and double emulsion methods. Eur J Pharm Biopharm. 2007;66(3): 488-492.
20. Miklavcic D, Jarm T, Cemazar M, et al. Tumor treatment by direct electric current. Tumor perfusion changes. Bioelectrochem Bioenerg. 1997;43:253-256.
21. Nilsson E, von Euler H, Berendson J, et al. Electrochemical treatment of tumours. Bioelectrochemistry. 2000;51(1):1-11.
22. Ciria HC, Quevedo MS, Cabrales LB, et al. Antitumor effectiveness of different amounts of electrical charge in Ehrlich and fibrosarcoma Sa-37 tumors. BMC Cancer. 2004;4:87.
23. Nordenström BEW. Biologically closed electric circuits: activation of vascular interstitial closed electric circuits for treatment of inoperable cancers. Bioelectromagnetics. 1984;3:137-153.
24. Nordenström BE. Electrochemical treatment of cancer. I: Variable response to anodic and cathodic fields. Am J Clin Oncol. 1989;12(6):530-536.
25. Nordenström BE. Survey of mechanisms in electrochemical treatment (ECT) of cancer. Eur J Surg Suppl. 1994;(574):93-109.
26. Nordenström BEW. Preliminary clinical trials of electrophoretic ionization in the treatment of malignant tumors. IRCS Med Sci Biomed Technol. 1978;6:537-540.
27. Nordenström BE, Eksborg S, Beving H. Electrochemical treatment of cancer. II: Effect of electrophoretic influence on adriamycin. Am J Clin Oncol. 1990;13(1):75-88.
28. Holandino C, Veiga VF, Rodrigues ML, Morales MM, Capella MA, Alviano CS. Direct current decreases cell viability but not P-glycoprotein expression and function in human multidrug resistant leukemic cells. Bioelectromagnetics. 2001;22(7):470-478.
29. Veiga V, Holandino C, Rodrigues M, Capella M, Menezes S, Alviano C. Cellular damage and altered carbohydrate expression in P815 tumor cells induced by direct electric current: an in vitro analysis. Bioelectromagnetics. 2000;21(8):597-607.
30. Veiga VF, Nimrichter L, Teixeira CA, et al. Exposure of human leukemic cells to direct electric current: generation of toxic compounds inducing cell death by different mechanisms. Cell Biochem Biophys. 2005;42(1):61-74.
31. Wagner BA, Britigan BE, Reszka KJ, McCormick ML, Burns CP. Hydrogen peroxide-induced apoptosis of HL-60 human leukemia cells is mediated by the oxidants hypochlorous acid and chloramines. Arch Biochem Biophys. 2002;401(2):223-234.
32. Englert RP, Shacter E. Distinct modes of cell death induced by different reactive oxygen species: amino acyl chloramines mediate hypochlorous acid-induced apoptosis. J Biol Chem. 2002;277(23):20518-20526.
33. Santoyo S, Ga de Jalón E, Ygartua P, Renedo M, Blanco-Príeto M. Optimization of topical cidofovir penetration using microparticles. Int J Pharm. 2002;242(1-2):107-113.
34. Hasan AS, Socha M, Lamprecht A, et al. Effect of the microencapsulation of nanoparticles on the reduction of burst release. Int J Pharm. 2007;344(1-2):53-61.
35. Ricci-Júnior E, Marchetti JM. Zinc(II) phthalocyanine loaded PLGA nanoparticles for photodynamic therapy use. Int J Pharm. 2006; 310(1-2):187-195.
36. Fonseca ME, Frimer N, Mendonça RE, Couceiro JN, Machado RD. A combined staining technique developed for virus particle observation in the electron microscope. Rev Bras Biol. 1984;44(1):37-40.
37. Freshney NW, Goonesekera SD, Feig LA. Activation of the exchange factor Ras-GRF by calcium requires an intact Dbl homology domain. FEBS Lett. 1997;407(1):111-115.
38. Holandino C, Veiga VF, Capella MM, Menezes S, Alviano CS. Damage induction by direct electric current in tumoural target cells. Indian J Exp Biol. 2000;38(6):554-558.
39. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65(1-2):55-63.
40. Meira DD, Marinho-Carvalho MM, Teixeira CA, et al. Clotrimazole decreases human breast cancer cells viability through alterations in cytoskeleton-associated glycolytic enzymes. Mol Genet Metab. 2005; 84(4):354-362.
41. Kong G, Braun RD, Dewhirst MW. Hyperthermia enables tumorspecific nanoparticle delivery: effect of particle size. Cancer Res. 2000; 60(16):4440-4445.
42. Yang YY, Chung TS, Ng NP. Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/ evaporation method. Biomaterials. 2001;22(3):231-241.
43. Graf A, Ablinger E, Peters S, Zimmer A, Hook S, Rades T. Microemulsions containing lecithin and sugar-based surfactants: nanoparticle templates for delivery of proteins and peptides. Int J Pharm. 2008;350(1-2):351-360.
44. Lince F, Marchisio DL, Barresi AA. Strategies to control the particle size distribution of poly-epsilon-caprolactone nanoparticles for pharmaceutical applications. J Colloid Interface Sci. 2008;322(2): 505-515.
45. Holandino C, Capella MA, Angluster J, Silva-Filho FC, Menezes S, Alviano CS. Cell surface alterations induced by methylene blue and direct electric current in Escherichia coli. Indian J Biochem Biophys. 1998;35(5):284-290.
46. Janigro D, Perju C, Fazio V, et al. Alternating current electrical stimulation enhanced chemotherapy: a novel strategy to bypass multidrug resistance in tumor cells. BMC Cancer. 2006;6:72.
47. Colombo L, González G, Marshall G, et al. Ion transport in tumors under electrochemical treatment: in vivo, in vitro and in silico modeling. Bioelectrochemistry. 2007;71(2):223-232.
48. Sersa G, Miklavcic D, Cemazar M, Rudolf Z, Pucihar G, Snoj M. Electrochemotherapy in treatment of tumours. Eur J Surg Oncol. 2008; 34(2):232-240.
49. Peskin AV, Winterbourn CC. Histamine chloramine reactivity with thiol compounds, ascorbate, and methionine and with intracellular glutathione. Free Radic Biol Med. 2003;35(10):1252-1260.
50. Klamt F, Shacter E. Taurine chloramine, an oxidant derived from neutrophils, induces apoptosis in human B lymphoma cells through mitochondrial damage. J Biol Chem. 2005;280(22): 21346-21352.
51. Salzberg M, Kirson E, Palti Y, Rochlitz C. A pilot study with very low-intensity, intermediate-frequency electric fields in patients with locally advanced and/or metastatic solid tumors. Onkologie. 2008;31: 362-365.
52. Griffin DT, Dodd NJ, Moore JV, Pullan BR, Taylor TV. The effects of low level direct current therapy on a preclinical mammary carcinoma: tumor regression and systemic biochemical sequelae. Br J Cancer. 1994;69(5):875-878.
53. Fosh BG, Finch JG, Lea M, et al. Use of electrolysis as an adjunct to liver resection. Br J Surg. 2002;89(8):999-1002.
54. Plesnicar A, Sersa G, Vodovnik L, Jancar J, Zaletel-Kragelj L, Plesnicar S. Electric treatment of human melanoma skin lesions with low level direct electric current: an assessment of clinical experience following a preliminary study in five patients. Eur J Surg Suppl. 1994;(574): 45-49.